|Articles|July 1, 2012
- Pharmaceutical Executive-07-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - July 2012
2012 Emerging Pharma Leaders
Advertisement
Articles in this issue
almost 14 years ago
Emerging Pharma Leaders 2012almost 14 years ago
Who Will Pay for New Drugs?almost 14 years ago
Less, But Betteralmost 14 years ago
John Lechleiter on PhRMA and Innovationalmost 14 years ago
Today's Mission Critical: Making Sense of Spending on Clinical Trialsalmost 14 years ago
The Learning Curvealmost 14 years ago
Marketing: Why the Conversation Has Changed — ForeverAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
How New Technologies Are Impacting the Vaccine Market
2
Pharmaceutical Executive Daily: Kardigan Sets Terms for $350 Million IPO
3
Deepening Ties: Why China is Becoming Big Pharma's Most Essential R&D Partner
4
Zepzelca Fails to Meet Main Goal of Phase III Lagoon Trial in Second-Line Small Cell Lung Cancer
5